Home

DAVID SCHREIBER

CIK 1255627 · last filed 2021-03-23

DAVID SCHREIBER is a corporate insider who has filed 14 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for AWH, was dated Mar 23, 2021. Across all open-market trades the lifetime net is −$180.0K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $186.3K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$186.3K

Companies

4

Total Filings

14

Lifetime Open-Market Net

-$180.0K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Aspira Women's Health Inc. (AWH) Delisted Director 11,435 $0.08 $938 -$139.0K 2 2021-03-23
Aspira Women's Health Inc. (VRML) Delisted Director 235,018 — — -$41.0K 8 2020-03-23
RESPONSE GENETICS INC (RGDX) Delisted Director — — — $0 2 2014-07-11
NGEN Director 108,922 $1.71 $186.3K $0 2 2008-07-01

Recent Filings

14 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2021-03-23 Aspira Women's Health Inc. (AWH) Delisted Grant (A) +4,031 $0 EDGAR
2020-09-10 Aspira Women's Health Inc. (AWH) Delisted Sell (S) −50,000 -$139.0K EDGAR
2020-03-23 Aspira Women's Health Inc. (VRML) Delisted Grant (A) +70,113 $0 EDGAR
2019-06-04 Aspira Women's Health Inc. (VRML) Delisted Sell (S) −10,000 -$11.0K EDGAR
2019-03-28 Aspira Women's Health Inc. (VRML) Delisted Grant (A) +37,500 $0 EDGAR
2019-03-11 Aspira Women's Health Inc. (VRML) Delisted Sell (S) −30,000 -$30.0K EDGAR
2018-04-17 Aspira Women's Health Inc. (VRML) Delisted Grant (A) +79,200 $0 EDGAR
2017-03-27 Aspira Women's Health Inc. (VRML) Delisted Grant (A) +26,250 $0 EDGAR
2016-03-21 Aspira Women's Health Inc. (VRML) Delisted Grant (A) +30,909 $0 EDGAR
2015-07-15 Aspira Women's Health Inc. (VRML) Delisted Grant (A) +28,091 $0 EDGAR
Showing 1–10 of 14
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.